Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...
Zacks Investment Research on MSN
Strength seen in Bioventus (BVS): Can its 6.6% jump turn into more strength?
Bioventus (BVS) shares rallied 6.6% in the last trading session to close at $10.56. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...
At 2 years, there are no significant differences with regard to clinical outcomes between the Absorb everolimus-eluting bioresorbable scaffold and the Xience everolimus-eluting stent, according to ...
BIOVENTUS ($BVS) is expected to release its quarterly earnings data on Tuesday, March 11th before market open, per Finnhub. Analysts are expecting revenue of ...
View Bioventus, Inc. Class A BVS stock quote prices, financial information, real-time forecasts, and company news from CNN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results